Mangoceuticals, INC. (MGRX) — DEF 14A Filings
All DEF 14A filings from Mangoceuticals, INC.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Mangoceuticals Files Definitive Proxy Statement
— Feb 18, 2025 Risk: low
Mangoceuticals, Inc. filed its definitive proxy statement on February 18, 2025, for its annual meeting. The company, located at 15110 Dallas Pkwy, Suite 600, Da -
Mangoceuticals Files Definitive Proxy Statement
— May 16, 2024 Risk: low
Mangoceuticals, Inc. filed its definitive proxy statement on May 16, 2024, for its annual meeting. The filing outlines the company's governance, executive compe -
Mangoceuticals, Inc. Schedules Special Stockholder Meeting for March 25, 2024
— Mar 1, 2024 Risk: low
MANGOCEUTICALS, INC. (MGRX) filed a Proxy Statement (DEF 14A) with the SEC on March 1, 2024. Mangoceuticals, Inc. is holding a special meeting of stockholders o
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX